Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Takeda
Polycythemia Vera
Japan
Sponsor: Takeda
Myelofibrosis · Anemia
United States, Argentina, Australia, Austria, Belgium +26 more
- A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid TumorsActive Not Recruiting
Sponsor: Ono Pharmaceutical Co., Ltd.
Solid Tumor · NSCLC
Japan
Sponsor: National Cancer Center, Japan
Gastric Adenocarcinoma · Gastroesophageal Junction (GEJ) Adenocarcinoma
Japan, South Korea
- A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
United States, Australia, Belgium, Brazil, Chile +14 more
- AB122 Platform StudyRecruiting
Sponsor: Taiho Pharmaceutical Co., Ltd.
Advanced or Metastatic Solid Tumor · Pancreatic Ductal Adenocarcinoma · Colorectal Cancer · Non-small Cell Lung Cancer
Japan
- A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic SyndromesRecruiting
Sponsor: Takeda
Myelodysplastic Syndromes
Japan
Sponsor: Merck Sharp & Dohme LLC
Endometrial Cancer
United States, Argentina, Australia, Austria, Belgium +29 more
Sponsor: Pliant Therapeutics, Inc.
Idiopathic Pulmonary Fibrosis
United States, Argentina, Australia, Belgium, Brazil +20 more
Sponsor: AbbVie
Plaque Psoriasis
Canada, Czechia, France, Germany, Greece +3 more
Sponsor: Kyorin University
Primary Central Nervous System Lymphoma
Japan
- DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine CancersActive Not Recruiting
Sponsor: Boehringer Ingelheim
Neuroendocrine Neoplasms
United States, Belgium, France, Germany, Japan +3 more
Sponsor: VectivBio AG
Short Bowel Syndrome (SBS) · SBS Associated With Intestinal Failure (SBS-IF)
United States, Argentina, Australia, Austria, Belgium +17 more
- A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus ErythematosusEnrolling By Invitation
Sponsor: Biogen
Subacute Cutaneous Lupus Erythematosus · Chronic Cutaneous Lupus Erythematosus
United States, Argentina, Brazil, Bulgaria, Canada +20 more
- Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung CancerRecruiting
Sponsor: Genmab
Non-small Cell Lung Cancer (NSCLC)
United States, Australia, Belgium, China, France +7 more
Sponsor: Genmab
Gastrointestinal Cancers
United States, Japan
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus
United States, Australia, Bulgaria, Canada, China +8 more
Sponsor: NRG Oncology
Breast Cancer
United States, Canada, Colombia, Japan, Mexico +3 more
- A Survey of Lanadelumab in Participants With Hereditary AngioedemaActive Not Recruiting
Sponsor: Takeda
Hereditary Angioedema (HAE)
Japan
Sponsor: Ono Pharmaceutical Co., Ltd.
Rhabdoid Tumor
Japan
- Spinal Cord Stimulation for Poststroke SpasticityNot Yet Recruiting
Sponsor: Beijing Pins Medical Co., Ltd
Spasticity Post Stroke
China
- Phase IIa Study Evaluating AZD7798 in Crohn's DiseaseActive Not Recruiting
Sponsor: AstraZeneca
Moderate to Severe Crohn's Disease
United States, Argentina, Australia, Belgium, Brazil +21 more
- Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)Recruiting
Sponsor: Genmab
High Grade Epithelial Ovarian Cancer · High Grade Serous Ovarian Cancer · Primary Peritoneal Carcinoma · Fallopian Tube Cancer
United States, China, Japan
Sponsor: Novo Nordisk A/S
Obesity · Overweight · Obstructive Sleep Apnoea
United States, Australia, China, Germany, India +5 more
Sponsor: AusperBio Therapeutics Inc.
Hepatitis B, Chronic
Australia, China, Japan, New Zealand, Singapore +2 more